GO TO the newsroom
UPDATE 3:50 PM PT – Friday, October 30, 2020
‘Regeneron’ has suspended testing in the most ill-fated patients due to safety concerns.
According to reports on Friday, the pharmaceutical company has decided to stop providing antibodies to coronavirus patients on ventilators or those receiving high oxygen levels.
Update notification of patient # COVID19 hospitalized during the ongoing P2 / 3 study of Regeneron’s investigative antibody cocktail: https://t.co/6maNUOpruE pic.twitter.com/4xG0gg0qbT
– Regeneron (@Regeneron) October 30, 2020
However, the company says it will continue to test patients with milder illnesses.
This happened when another pharmaceutical company, ‘Eli Lilly,’ ended its trial on hospitalized patients on Monday after the drug was found to be ineffective for severe cases of coronavirus.